Bionoid Pharma Inc. (BINP)

USD 0.29

(104.23%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019 2013
Revenue 37.5 Thousand 36.04 Thousand 102.12 Thousand 30.65 Thousand 56.17 Thousand 92.26
Cost of Revenue 29.08 Thousand 18.69 Thousand 56.11 Thousand 16.58 Thousand - 44.77
Gross Profit 8417.00 17.34 Thousand 46.01 Thousand 14.07 Thousand 56.17 Thousand 47.48
Operating Expenses 15.74 Thousand 15.49 Thousand 125.84 Thousand 46.55 Thousand 16.69 Thousand 1599.46
Selling, General and Administrative Expenses 15.74 Thousand 15.49 Thousand 125.84 Thousand 3251.00 16.69 Thousand 436.25
Research and Development Expenses - - - - - 0.26
Other Expenses - - - -43.3 Thousand - -
Cost and Expenses 44.83 Thousand 34.18 Thousand 181.95 Thousand 63.13 Thousand 19.69 Thousand 1644.23
Operating Income -7324.00 1860.00 -79.83 Thousand -32.48 Thousand 36.48 Thousand -389.02
Interest Expense 481.00 380.00 393.00 - 202.00 -
Income Tax Expense -7805.00 2.00 -1.00 - - 1.97
Earnings before Tax -7805.00 1478.00 -135.25 Thousand -455.78 Thousand 27.14 Thousand -1620.97
Net Income -7805.00 1478.00 -135.25 Thousand -455.78 Thousand 27.14 Thousand -1622.95
Earnings Per Share Basic -0.00 - -0.00 -11.88 0.70 -46.37
Earnings Per Share Diluted -0.00 - -0.00 -11.88 0.70 -46.27
Weighted Average Shares Outstanding 53.99 Million 53.99 Million 42.66 Million 38.35 Thousand 38.22 Thousand 35.00
Weighted Average Shares Outstanding (Diluted) 53.99 Million 53.99 Million 42.66 Million 38.35 Thousand 38.22 Thousand 35.07
Gross Margin 0.22 0.48 0.45 0.46 1.00 0.51
EBIT Margin -0.12 0.13 -0.75 -0.96 0.70 -4.18
Profit Margin -0.21 0.04 -1.32 -14.87 0.48 -17.59
EBITDA -4324.00 4860.00 -131.86 Thousand -29.48 Thousand 30.34 Thousand -385.71
Earnings Before Tax Margin -0.20 0.05 -0.78 -1.06 0.65 -4.22

Income Statement Charts